Kuros Biosciences AG CSBTF
$26.99
Last Updated: Aug 17, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
CSBTF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Kuros Biosciences AG is classified as halal.
HALAL
Report Source: undefined Quarter Report
Kuros Biosciences AG. Stock Analysis CSBTF
United States Health Care Small Cap Kuros Biosciences Ltd. operates as biopharmaceutical company, which engages in developing products for tissue repair and bone regeneration. The company is headquartered in Schlieren, Zuerich and currently employs 178 full-time employees. The company went IPO on 2002-10-29. The firm's key product is MagnetOs, which is a synthetic bone graft technology available in multiple formats such as granules or putty. MagnetOs is designed to stimulate bone formation, including through mechanisms that engage the body’s immune response. The technology behind MagnetOs is associated with osteoimmunology, which involves immune‑modulated bone healing. MagnetOs uses the proprietary NeedleGrip submicron surface technology, which supports bone growth by enhancing biological responses related to healing. The company is indicated for use across the skeletal system and is positioned as a bone graft option for procedures involving various anatomical regions.
Kuros Biosciences AG (CSBTF) Chart
Financial Metrics & Statements of Kuros Biosciences AG (CSBTF)
FAQ's for Kuros Biosciences AG (CSBTF)
- As of August 2026, Kuros Biosciences AG CSBTF is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Kuros Biosciences AG using these criteria to determine its compliance status.
- Muslim investors may consider investing in Kuros Biosciences AG if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Kuros Biosciences AG by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Kuros Biosciences AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Kuros Biosciences AG on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Kuros Biosciences AG (CSBTF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
